DE69124591D1 - Mehrkomponentenwirkstoff oder Kit zur Herstellung von sulfokonjugierten Formen von Pyridino-, Pyrimidino- oder Triazino-N-Oxydeverbindungen und Verfahren zu ihrer Verwendung - Google Patents

Mehrkomponentenwirkstoff oder Kit zur Herstellung von sulfokonjugierten Formen von Pyridino-, Pyrimidino- oder Triazino-N-Oxydeverbindungen und Verfahren zu ihrer Verwendung

Info

Publication number
DE69124591D1
DE69124591D1 DE69124591T DE69124591T DE69124591D1 DE 69124591 D1 DE69124591 D1 DE 69124591D1 DE 69124591 T DE69124591 T DE 69124591T DE 69124591 T DE69124591 T DE 69124591T DE 69124591 D1 DE69124591 D1 DE 69124591D1
Authority
DE
Germany
Prior art keywords
triazino
pyrimidino
pyridino
kit
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69124591T
Other languages
English (en)
Other versions
DE69124591T2 (de
Inventor
Quintino Gaetani
Andre Rougier
Albert Duranton
Michel Hocquaux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of DE69124591D1 publication Critical patent/DE69124591D1/de
Publication of DE69124591T2 publication Critical patent/DE69124591T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69124591T 1990-12-28 1991-12-20 Mehrkomponentenwirkstoff oder Kit zur Herstellung von sulfokonjugierten Formen von Pyridino-, Pyrimidino- oder Triazino-N-Oxydeverbindungen und Verfahren zu ihrer Verwendung Expired - Fee Related DE69124591T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9016504A FR2671082B1 (fr) 1990-12-28 1990-12-28 Agent a plusieurs composants ou kit de preparation de la forme sulfo-conjuguee de composes pyrimidino- ou triazino-n-oxyde et procede de mise en óoeuvre.

Publications (2)

Publication Number Publication Date
DE69124591D1 true DE69124591D1 (de) 1997-03-20
DE69124591T2 DE69124591T2 (de) 1997-05-28

Family

ID=9403848

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69124591T Expired - Fee Related DE69124591T2 (de) 1990-12-28 1991-12-20 Mehrkomponentenwirkstoff oder Kit zur Herstellung von sulfokonjugierten Formen von Pyridino-, Pyrimidino- oder Triazino-N-Oxydeverbindungen und Verfahren zu ihrer Verwendung

Country Status (8)

Country Link
US (1) US5360804A (de)
EP (1) EP0494005B1 (de)
JP (1) JP3115072B2 (de)
AT (1) ATE148629T1 (de)
CA (1) CA2058471A1 (de)
DE (1) DE69124591T2 (de)
ES (1) ES2097198T3 (de)
FR (1) FR2671082B1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010049381A1 (en) 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
US6187784B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US6187796B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Sulfone hair growth compositions and uses
US6274602B1 (en) 1998-06-03 2001-08-14 Gpi Nil Holdings, Inc. Heterocyclic thioester and ketone hair growth compositions and uses
US6271244B1 (en) 1998-06-03 2001-08-07 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
AU1708099A (en) 1998-06-03 1999-12-20 Amgen, Inc. N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
US6172087B1 (en) 1998-06-03 2001-01-09 Gpi Nil Holding, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
EP1085853A1 (de) 1998-06-03 2001-03-28 GPI NIL Holdings, Inc. Haarwuchszusammensetzungen basiernd auf heterozyklischem ester und amid und anwendungen
WO1999062486A1 (en) * 1998-06-03 1999-12-09 Gpi Nil Holdings Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
US6429215B1 (en) 1998-06-03 2002-08-06 Gpi Nil Holdings, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
DE19845202A1 (de) * 1998-10-01 2000-04-06 Wella Ag Haarwuchsmittel
GB2423087A (en) * 2005-02-07 2006-08-16 Reckitt Benckiser A method of forming a surface treatment liquid,of treating a surface, of cleaning a surface and a packaged composition therefor
WO2006091587A2 (en) * 2005-02-22 2006-08-31 Cedars-Sinai Medical Center Use of minoxidil sulfate as an anti-tumor drug
JP7194553B2 (ja) * 2017-10-12 2022-12-22 ロート製薬株式会社 外用組成物
US11766392B2 (en) * 2018-10-05 2023-09-26 Jupiter Wellness, Inc. Minoxidil adjuvant therapies
US11628132B2 (en) 2018-10-05 2023-04-18 Jupiter Wellness, Inc. Minoxidil adjuvant therapies

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053113A (de) * 1963-04-19
US3270018A (en) * 1964-02-13 1966-08-30 Upjohn Co 1, 3, 5-triazine ethers
US3270014A (en) * 1965-07-01 1966-08-30 Upjohn Co 1, 2-dihydro-1-hydroxy-1, 3, 5-triazines
US3348943A (en) * 1965-08-27 1967-10-24 Bernard D Pollock Refractory metal dispersion
US3910928A (en) * 1974-04-26 1975-10-07 Upjohn Co 3-(Cyanimino)-propionitriles
US4032559A (en) * 1975-07-28 1977-06-28 The Upjohn Company N,2-dicyanoacetimidates
US4287338A (en) * 1980-03-10 1981-09-01 The Upjohn Company Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts
EP0210227B1 (de) * 1985-01-25 1990-05-02 The Upjohn Company Pyrimidinsulfate für haarwuchs
JPS62158204A (ja) * 1985-12-28 1987-07-14 Banyu Pharmaceut Co Ltd 育毛剤
LU87308A1 (fr) * 1988-08-01 1990-03-13 Oreal Nouveaux derives de diamino-2,4 pyrimidine oxyde-3 et leur utilisation pour le traitement et la prevention de la chute des cheveux
FR2657609B1 (fr) * 1990-01-31 1992-04-30 Oreal Nouveaux derives de pyrimidine oxyde-3 halogenes, leur utilisation pour le traitement et la prevention de la chute des cheveux et pour stimuler leur repousse.
FR2651122B1 (fr) * 1989-08-29 1994-10-28 Oreal Compositions destinees a etre utilisees pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives de l'amino-2 pyrimidine oxyde-3 et nouveaux composes derives de l'amino-2 pyrimidine oxyde-3.
FR2662607B1 (fr) * 1990-05-30 1992-08-28 Oreal Composition destinee a etre utilisee pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives d'alkyl-2 amino-4 (ou dialkyl-2-4) pyrimidine oxyde-3 .
FR2663327B1 (fr) * 1990-06-19 1992-09-25 Oreal Nouveaux derives de diamino-2,4 triazine-1,3,5 et leur utilisation pour le traitement et la prevention de la chute des cheveux.

Also Published As

Publication number Publication date
CA2058471A1 (fr) 1992-06-29
DE69124591T2 (de) 1997-05-28
ATE148629T1 (de) 1997-02-15
EP0494005B1 (de) 1997-02-05
JPH04308576A (ja) 1992-10-30
US5360804A (en) 1994-11-01
JP3115072B2 (ja) 2000-12-04
ES2097198T3 (es) 1997-04-01
EP0494005A1 (de) 1992-07-08
FR2671082B1 (fr) 1993-04-16
FR2671082A1 (fr) 1992-07-03

Similar Documents

Publication Publication Date Title
DE69124591T2 (de) Mehrkomponentenwirkstoff oder Kit zur Herstellung von sulfokonjugierten Formen von Pyridino-, Pyrimidino- oder Triazino-N-Oxydeverbindungen und Verfahren zu ihrer Verwendung
DE68910654T2 (de) Beschichtungszusammensetzung und Verfahren zu ihrer Herstellung.
DE3672271D1 (de) Reinigungsmittel, deren bestandteile und verfahren zu deren herstellung.
DE68912932D1 (de) Glas-Keramik-Gegenstand und Verfahren zu dessen Herstellung.
DE68912657D1 (de) Verfahren zur Herstellung von 1,1,1,2-Tetrafluorethan.
DE69011473D1 (de) Gummidichtungen und Verfahren zu ihrer Herstellung.
DE69004764T2 (de) Harzzusammensetzung und Verfahren zu ihrer Herstellung.
DE3884069T2 (de) Polysilazan und Verfahren zu dessen Herstellung.
DE68912160T2 (de) Verfahren zur Herstellung von beta-Lactamderivaten.
DE69410722D1 (de) Verfahren zur Herstellung 1,4-bissubstituierter-5(4H)-Tetrazolinone
DE68924233D1 (de) Entwicklerzusammensetzung und Verfahren zu deren Herstellung.
DE69205804T2 (de) Vulkanisierbare Fluorkautschukzusammensetzung und Verfahren zu ihrer Herstellung.
DE69006911D1 (de) Verfahren zur Herstellung von 3,4-Dichloranilin.
DE59408701D1 (de) Verfahren zur Herstellung von 2,3,4,5-Tetrafluor-benzotrifluorid
DE69400342D1 (de) Verfahren zur Herstellung von 1,1,1,2-Tetrafluor-2-Chlorethan und Pentafluorethan
DE59407675D1 (de) Verfahren zur Herstellung von 6H-Dibenz-(c,e)(1,2)-oxaphosphorin-6-on
DE69408085D1 (de) Verfahren zur Herstellung von 2,2-Diphenylhexafluorpropanen
DE59305733D1 (de) Verfahren zur Herstellung von 1,3-Difluorbenzol
DE3879904D1 (de) Klebmischung, verfahren zu deren herstellung und verwendung.
DE69401368T2 (de) Verfahren zur Herstellung von 1,4-Dicyano-2-buten
DE69009394T2 (de) Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethyl-1-cyclohexanon.
ATE100437T1 (de) Bronchospasmolytische verbindungen und verfahren zu ihrer herstellung.
DE68919887T2 (de) Verfahren zur Herstellung von 1-alpha,25-dihydroxy-vitamin D2 und dessen 24-Epimer.
DE3783728T2 (de) Sichere pestizide harzzusammensetzungen zur bekaempfung von bodenbuertigen krankheiten und verfahren zu deren herstellung.
DE3867861D1 (de) Mehlzusammensetzung und verfahren zu deren herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee